BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6035187)

  • 1. [A method of fractionating urinary peptides containing hydroxyproline].
    Borel JP; Caranjot JM; Jayle MF
    Clin Chim Acta; 1967 Jun; 16(3):409-16. PubMed ID: 6035187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Valve and significance of urinary hydroxyproline in osseous pathology].
    Hioco D; Gruson M; Ryckewaert A; de Sèze S
    Ann Biol Clin (Paris); 1967; 25(5):725-34. PubMed ID: 6059731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of urinary hydroxyproline in osteopathies].
    Kocher P
    Pathol Biol; 1966 Nov; 14(21):1020-39. PubMed ID: 5339820
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between urine zinc and hydroxyproline in rheumatoid arthritis and bone diseases.
    Ambanelli U; Ferraccioli GF; Bernardi P; Servemti G
    J Rheumatol; 1978; 5(4):477-9. PubMed ID: 739496
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of the urinary hydroxyproline level in the screening for collagen diseases].
    Gambella GR; Zunino M
    Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
    Szymanowicz A; Malgras A; Cosson R; Randoux A; Borel JP
    Ann Biol Clin (Paris); 1975; 33(5):351-8. PubMed ID: 1217759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
    Courvoisier B; Zender R
    Schweiz Med Wochenschr; 1972 Feb; 102(5):160-6. PubMed ID: 5010800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications for urinary hydroxyproline determination].
    Burkhardt H; Wepler R; Rommel K
    Dtsch Med Wochenschr; 1976 Sep; 101(38):1394-7. PubMed ID: 782814
    [No Abstract]   [Full Text] [Related]  

  • 9. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
    Russell RG; Hodgkinson A
    Clin Sci; 1969 Jun; 36(3):435-43. PubMed ID: 4307562
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary hydroxyproline excretion in coalworkers' pneumoconiosis.
    Resnick H; Lapp NL; Morgan WK
    Br J Ind Med; 1969 Apr; 26(2):135-8. PubMed ID: 5780105
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H; Raab W
    Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary polypeptides related to collagen synthesis.
    Krane SM; Muñoz AJ; Harris ED
    J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondialyzable urinary hydroxyproline as an index of bone collagen formation.
    Haddad JG; Couranz S; Avioli LV
    J Clin Endocrinol Metab; 1970 Mar; 30(3):282-7. PubMed ID: 4983851
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
    Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
    Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyproline.
    Niejadlik DC
    Postgrad Med; 1972 May; 51(5):213-6. PubMed ID: 5025220
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical significance of hydroxyproline in the urine].
    Emmrich R; Häntzschel HJ; Häntzschel H
    Z Gesamte Inn Med; 1967 Apr; 22(7):193-9. PubMed ID: 5596343
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE; Pachas WN; Pinals RS; Krant MJ
    Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of estradiol and estriol on urinary excretion of hydroxyproline in man.
    Katz FH; Kappas A
    J Lab Clin Med; 1968 Jan; 71(1):65-74. PubMed ID: 5635010
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
    Mühlbach R; Hirthe D; Lindenhayn K
    Z Arztl Fortbild (Jena); 1966 May; 60(10):597-602. PubMed ID: 5997685
    [No Abstract]   [Full Text] [Related]  

  • 20. [Creatinine-hydroxyproline index in healthy subjects, in hyperthyroidism and in bone neoplasms].
    Radom S; Sienczewska-Burzyńska J; Jaruga-Dolińska E; Zulawski M
    Pol Arch Med Wewn; 1971 Sep; 47(3):257-64. PubMed ID: 5171080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.